(MedPage Today) — More and more patients who undergo bariatric surgery are starting a GLP-1 receptor agonist, according to a retrospective cohort study.
Among over 112,000 patients, 14% started a GLP-1 agent after undergoing bariatric surgery…
Source link : https://www.medpagetoday.com/endocrinology/obesity/117186
Author :
Publish date : 2025-08-27 21:17:00
Copyright for syndicated content belongs to the linked Source.
